Investing Profile

Abe Bassan

InvestorVC
Vice President at Samsara BioCapital
samsaracap.com/abe-bassan/San Francisco Bay Area
Photo of Abe Bassan, Vice President at Samsara BioCapital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Stanford University Network
1257 CONNECTIONS
Princeton University Network
335 CONNECTIONS
Third Rock Ventures Network
50 CONNECTIONS
Samsara BioCapital Network
13 CONNECTIONS
Samsara BioCapital Network
13 CONNECTIONS
cb
Samsara BioCapital Vice President
$10.0M - $100.0M
$25.0M
6
$310.1M
CompanyStageDateRound SizeTotal Raised
Link Cell Therapies
Series ADec 2025$60M
SeedMay 2022$12M
$72M
Septerna
Series BJul 2023$150M
Series AJan 2022$100M
$250M
Co-investors: Alan Ezekowitz (Third Rock Ventures), Jeffrey Finer (Third Rock Ventures), Jeffrey Tong (Third Rock Ventures), Jake Simson (RA Capital Management)
Graphite Bio
Series BMar 2021$150M
Series ASep 2020$45M
$200M
Co-investors: Carlo Rizzuto (Versant Ventures), Jerel Davis (Versant Ventures), Jake Simson (RA Capital Management)
Associate Third Rock VenturesPresent
Associate Director, Program Management Bluebird BioPresent
Associate Director, Program Development Bluebird BioPresent
Director, Project Management REVOLUTION MedicinesPresent
Director, Program Biology REVOLUTION MedicinesPresent
Investing / Company Building Samsara BioCapitalPresent
Principal Samsara BioCapitalPresent
Vice President Samsara BioCapitalPresent
Founder & CEO Aurora Medical, Inc.Present
Princeton University AB Molecular Biology
Stanford University MS Developmental Biology
Sign in with Google →
Sign in with Google →